首页 › 基金 › BOONE CAPITAL MANAGEMENT LLC › BMRN
BOONE CAPITAL MANAGEMENT LLC 对 BMRN 的持仓历史
BIOMARIN PHARMACEUTICAL INC · 医疗保健
BOONE CAPITAL MANAGEMENT LLC 在 Q3 2026 的 13F 申报中披露持有 BMRN(BIOMARIN PHARMACEUTICAL INC)671,998 股,市值约 US$40.3M,约占其申报组合的 10.70%,在其申报持仓中市值排名第 1 位。 BOONE CAPITAL MANAGEMENT LLC 最近 7 个申报季度中有 7 个季度披露了 BMRN 持仓,最早可追溯至 Q1 2025。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
BOONE CAPITAL MANAGEMENT LLC 对 BMRN 的持仓演变
BOONE CAPITAL MANAGEMENT LLC 于 Q1 2025 首次披露 BMRN 持仓:327,279 股(约 US$23.1M)。 该持仓在 Q3 2026 达到峰值 671,998 股,市值约 US$40.3M。 在 7 次申报中,BOONE CAPITAL MANAGEMENT LLC 5 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 671,998 股、市值约 US$40.3M,环比增持 88,779 股。。 持仓曾出现大幅变动:Q2 2025 增持约 37% (随后一个季度股价下跌 1%)、Q3 2025 减持约 27% (随后一个季度股价上涨 10%)、Q1 2026 增持约 33% (随后一个季度股价上涨 1%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2025 | 327.28K | $23.14M | 新进 |
| Q2 2025 | 447.45K | $24.60M | 增持 |
| Q3 2025 | 328.55K | $17.79M | 减持 |
| Q4 2025 | 411.88K | $24.48M | 增持 |
| Q1 2026 | 547.87K | $30.95M | 增持 |
| Q2 2026 | 583.22K | $33.37M | 增持 |
| Q3 2026 | 672.00K | $40.32M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BMRN 与 13F 数据
BMRN(BIOMARIN PHARMACEUTICAL INC)属于医疗保健行业。我们追踪的基金中还有 27 只申报持有 BMRN,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), 维京环球投资 (US$435.8M), VIKING GLOBAL INVESTORS LP (US$430.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BMRN 的基金
- PRIMECAP MANAGEMENT CO/CA/ 14.99M 股 · $899.34M · Q3 2026
- 维京环球投资 7.62M 股 · $435.82M · Q2 2026
- VIKING GLOBAL INVESTORS LP 7.17M 股 · $430.39M · Q3 2026
- Deep Track Capital, LP 6.37M 股 · $382.46M · Q3 2026
- Vestal Point Capital, LP 5.53M 股 · $331.50M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.03M 股 · $121.51M · Q3 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 111.50M 股 · $109.58M · Q3 2026
更多关于 BOONE CAPITAL MANAGEMENT LLC
常见问题
How long has BOONE CAPITAL MANAGEMENT LLC held BMRN?
BOONE CAPITAL MANAGEMENT LLC has disclosed BMRN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is BOONE CAPITAL MANAGEMENT LLC's current position in BMRN?
As of Q3 2026, BOONE CAPITAL MANAGEMENT LLC holds 672.00K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $40.32M, representing 10.70% of its reported portfolio and ranking #1.
Has BOONE CAPITAL MANAGEMENT LLC been buying or selling BMRN?
In the latest 13F filing (Q3 2026), BOONE CAPITAL MANAGEMENT LLC increased its position in BMRN. The position peaked in Q3 2026 at 672.00K shares.
Which other funds hold BMRN?
Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, 维京环球投资, VIKING GLOBAL INVESTORS LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.